Article
Quiz: NCCN 2019 prostate Ca guideline emphasizing germline testing
Author(s):
The NCCN in 2019 updated its prostate cancer guideline to focus on the roles of germline and somatic genetic testing and risk stratification with nomograms and tumor multigene molecular testing, among other topics. These five questions will test your knowledge of the update.
Question 1
The expanded National Comprehensive Cancer Network (NCCN) criteria for a positive family history of prostate cancer includes which of the following?
A. Ashkenazi Jewish ancestry
B. First-order male relatives with prostate cancer history before age 60
C. Multiple cancers diagnosed on the same side of one’s family
D. All of the above
Related Videos
Neeraj Agarwal, MD, shares key takeaways from TALAPRO-2
Betty Wang, MD, recaps 3 key urologic cancer studies from EAU 2025
Neeraj Agarwal, MD, on the safety profile of talazoparib/enzalutamide in mCRPC
Rana McKay, MD, on persistence and adherence to relugolix for prostate cancer
Neeraj Agarwal, MD, on talazoparib/enzalutamide efficacy by HRR gene mutation status
Dr Louise Kostos on the rapidly evolving prostate cancer treatment landscape
An expert’s view on combination ARPI/ADT and long-term toxicity in prostate cancer
Rana McKay, MD, on the role of radium-223 in the modern era
Dr Louise Kostos discusses PSA kinetics in mHSPC
The importance of PSADT in high-risk, biochemically recurrent prostate cancer
Related Content
